Guidance
AMRIC have consolidated all existing CPE guidance into one overall consolidated guidance document V1.0 Management and Control of Carbapenemase Producing Enterobacterales (CPE) in all Healthcare Settings as at 20.12.22.
Please note Guidelines for control and prevention of MDRO excl MRSA in healthcare setting is no longer available. It has been replaced by NCEC National Clinical Guideline No. 30 Infection Prevention and Control which is available at the following link https://www.gov.ie/en/department-of-health/publications/infection-prevention-and-control-ipc/
Management and Control of Carbapenemase Producing Enterobacterales (CPE) in all Health and Social Care Settings
29, Sep 2025
725.14 KB
Guidance relating to the control of CPE and other AMRO in the Irish Prison Service
01, Jan 2020
509.73 KB
Irish Guidance
Guidance relating to healthcare workers colonised with CPE
07, May 2019
327.15 KB
A guide to treatment of infection with carbapenem resistant organisms
07, May 2019
698.52 KB
International Guidance
ECDC Guidance - Rapid risk assessment - Carbapenem-resistant Enterobacterales – third update
Published 2025
Information, Data and Reports for
Ireland’s specialist service for the surveillance of communicable diseases.